Sort
53,477 grants matching “addiction”
EFFECTS OF NICOTINE YIELD & NICOTINE REPLACEMENT ON VERY LOW NICOTINE CONTENT CIG
$4,799,454Eric Christian Donny · University Of Pittsburgh At Pittsburgh · U54 · FY2013 · DA
Tailored Retention and Engagement for Equitable Treatment of OUD and Pain (TREETOP)
$4,798,445Jessica S Merlin · University Of Pittsburgh At Pittsburgh · RM1 · FY2021 · DA
ABCD-USA Consortium: Twin Research Project
$4,791,106Monica M Luciana · University Of Minnesota · U01 · FY2017 · DA
Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder
$4,785,001Nikej Shah · Nirsum Laboratories, Inc. · U01 · FY2024 · DA
Health Systems Node of the NIDA Clinical Trials Network
$4,774,238Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2020 · DA
PET Radiopharmaceutical Sciences
$4,765,174Victor W Pike · National Institute Of Mental Health · ZIA · FY2023 · MH
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
$4,761,350William C Becker · Yale University · RM1 · FY2021 · DA
GENERAL CLINICAL RESEARCH CENTER
$4,743,796Peter L Slavin · Massachusetts General Hospital · M01 · FY2006 · RR
ABCD-USA Consortium: Twin Research Project
$4,720,631William G Iacono · University Of Minnesota · U01 · FY2016 · DA
RCMI@Morgan: Center for Urban Health Disparities Research and Innovation
$4,717,826Paul B Tchounwou · Morgan State University · U54 · FY2025 · MD
MEB-1170: A New Chemical Entity for the Treatment of Opioid Use Disorder
$4,710,576Lawrence C Kuo · Mebias Discovery, Inc. · UG3 · FY2025 · DA
The National Drug Abuse Treatment Clinical Trials Network
$4,700,000Roger D. Weiss · Mclean Hospital · UG1 · FY2019 · DA
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network
$4,687,361Thomas R Fleming · Fred Hutchinson Cancer Research Center · U01 · FY2006 · AI
EXERCISE THE OPTION ITEM UNDER THE CLINICAL TRIALS NETWORK CLINICAL COORDINATING CENTER. JULY 6, 2022 - JULY 5, 2023. TASK ORDER 6
$4,683,571Eve Jelstrom · The Emmes Company, Llc · N01 · FY2022 · DA
The Collaboration Linking Opioid Use Disorder and Sleep ("CLOUDS") Study
$4,672,265Henry Klar Yaggi · Yale University · U01 · FY2019 · HL
SDSU FUERTE: Faculty United towards Excellence in Research and Transformational Engagement
$4,668,857Maria Luisa Zuniga De Nuncio · San Diego State University · U54 · FY2024 · CA
Design and synthesis of drugs acting on central and peripheral tissues
$4,663,417Kenner C Rice · National Institute On Drug Abuse · Z01 · FY2007 · DA
TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29
$4,656,081The Emmes Company, Llc · N01 · FY2025 · DA
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)
$4,639,701Lorenzo Leggio · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2018 · AA
FY24 AWARD. NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2024 - SEPTEMBER 16, 2025. N01DA-21-5588. TASK ORDER 75N95024F00001 (TO4).
$4,639,112Michael Keller · Booz Allen Hamilton · N01 · FY2024 · DA
Developing small molecules to engage an analgesic GPCR in pain unpleasantness neural circuits
$4,637,933Gregory Scherrer · Univ Of North Carolina Chapel Hill · U19 · FY2024 · NS
Neuronal connectivity within the mesolimbic system
$4,635,053Marisela Morales · National Institute On Drug Abuse · ZIA · FY2022 · DA
Arylepoxamides: A new class of potent, safer analgesics
$4,628,029Jeffrey Reich · Sparian Biosciences, Inc. · UH3 · FY2022 · DA
Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy - Yale Resource Center (MIRHIQL-YRC)
$4,626,338William C Becker · Yale University · U24 · FY2023 · DA
IMPETUS: Integrated Mechanisms, Phenotypes, and Translational Underpinnings of Chronic Pain after Surgery
$4,618,885Simon Haroutounian · Washington University · RM1 · FY2024 · NS